APA (7th ed.) Citation

Luigi Gargiulo, Luciano Ibba, Carlo Alberto Vignoli, Paola Facheris, Mario Valenti, Antonio Costanzo, & Alessandra Narcisi. (2023). Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: A real-life 16-week experience. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Luigi Gargiulo, Luciano Ibba, Carlo Alberto Vignoli, Paola Facheris, Mario Valenti, Antonio Costanzo, and Alessandra Narcisi. Tralokinumab Rapidly Improves Subjective Symptoms and Quality of Life in Patients with Moderate-to-severe Atopic Dermatitis: A Real-life 16-week Experience. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Luigi Gargiulo, et al. Tralokinumab Rapidly Improves Subjective Symptoms and Quality of Life in Patients with Moderate-to-severe Atopic Dermatitis: A Real-life 16-week Experience. Taylor & Francis Group, 2023.